chr6-133259273-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004100.5(EYA4):​c.-65-15443G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.777 in 152,156 control chromosomes in the GnomAD database, including 46,468 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.78 ( 46468 hom., cov: 32)

Consequence

EYA4
NM_004100.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.308

Publications

5 publications found
Variant links:
Genes affected
EYA4 (HGNC:3522): (EYA transcriptional coactivator and phosphatase 4) This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may act as a transcriptional activator through its protein phosphatase activity, and it may be important for eye development, and for continued function of the mature organ of Corti. Mutations in this gene are associated with postlingual, progressive, autosomal dominant hearing loss at the deafness, autosomal dominant non-syndromic sensorineural 10 locus. The encoded protein is also a putative oncogene that mediates DNA repair, apoptosis, and innate immunity following DNA damage, cellular damage, and viral attack. Defects in this gene are also associated with dilated cardiomyopathy 1J. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
EYA4 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 10
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy 1J
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.88 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004100.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYA4
NM_004100.5
MANE Select
c.-65-15443G>T
intron
N/ANP_004091.3
EYA4
NM_001301013.2
c.-65-15443G>T
intron
N/ANP_001287942.1F2Z2Y1
EYA4
NM_172105.4
c.-65-15443G>T
intron
N/ANP_742103.1O95677-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYA4
ENST00000355286.12
TSL:1 MANE Select
c.-65-15443G>T
intron
N/AENSP00000347434.7O95677-1
EYA4
ENST00000531901.5
TSL:2
c.-65-15443G>T
intron
N/AENSP00000432770.1F2Z2Y1
EYA4
ENST00000883055.1
c.-65-15443G>T
intron
N/AENSP00000553114.1

Frequencies

GnomAD3 genomes
AF:
0.777
AC:
118098
AN:
152040
Hom.:
46423
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.888
Gnomad AMI
AF:
0.680
Gnomad AMR
AF:
0.806
Gnomad ASJ
AF:
0.653
Gnomad EAS
AF:
0.855
Gnomad SAS
AF:
0.753
Gnomad FIN
AF:
0.728
Gnomad MID
AF:
0.636
Gnomad NFE
AF:
0.715
Gnomad OTH
AF:
0.747
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.777
AC:
118199
AN:
152156
Hom.:
46468
Cov.:
32
AF XY:
0.776
AC XY:
57712
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.888
AC:
36899
AN:
41560
American (AMR)
AF:
0.806
AC:
12320
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.653
AC:
2264
AN:
3468
East Asian (EAS)
AF:
0.855
AC:
4431
AN:
5180
South Asian (SAS)
AF:
0.752
AC:
3625
AN:
4820
European-Finnish (FIN)
AF:
0.728
AC:
7691
AN:
10570
Middle Eastern (MID)
AF:
0.643
AC:
189
AN:
294
European-Non Finnish (NFE)
AF:
0.715
AC:
48585
AN:
67954
Other (OTH)
AF:
0.746
AC:
1576
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1290
2581
3871
5162
6452
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.754
Hom.:
10021
Bravo
AF:
0.789
Asia WGS
AF:
0.822
AC:
2856
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.42
DANN
Benign
0.51
PhyloP100
-0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs572004; hg19: chr6-133580411; COSMIC: COSV62059394; API